Chemical Compound

Uridine, 4-oxime, 5'-(2-methylpropanoate), (4Z)- (ACI); EIDD 1931-isopropyl ester; EIDD 2801; Lagevrio; MK-4482; Molnupiravir; ss-D-N4 hydroxycytidine-5'-isopropyl ester; Uridine (4Z)-4-oxime 5'-(2-methylpropanoate)

CAS Registry Number 2492423-29-5
Uridine, 4-oxime, 5'-(2-methylpropanoate), (4Z)- (ACI); EIDD 1931-isopropyl ester; EIDD 2801; Lagevrio; MK-4482; Molnupiravir; ss-D-N4 hydroxycytidine-5'-isopropyl ester; Uridine (4Z)-4-oxime 5'-(2-methylpropanoate) 结构式
Primary record

Uridine, 4-oxime, 5'-(2-methylpropanoate), (4Z)- (ACI); EIDD 1931-isopropyl ester; EIDD 2801; Lagevrio; MK-4482; Molnupiravir; ss-D-N4 hydroxycytidine-5'-isopropyl ester; Uridine (4Z)-4-oxime 5'-(2-methylpropanoate)

库存
6,495 克
纯度
98.6 %
CAS
2492423-29-5

化合物标识与属性

CAS
2492423-29-5
PubChem CID
145996610
SMILES
CC(C)C(=O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=CC(=NC2=O)NO)O)O
Canonical SMILES
CC(C)C(=O)OC[C@H]1O[C@@H](n2ccc(NO)nc2=O)[C@H](O)[C@@H]1O

名称与同义词

  • molnupiravir
  • EIDD-2801
  • Lagevrio
  • molnupiravirum
  • Molnupiravir RS
  • Molnupiravir [INN]
  • N4-Hydroxycytidine
  • Lagevrio (TN)
  • Molnupiravir [USAN]
  • 2492423-29-5
  • 2349386-89-4
  • YA84KI1VEW
  • Molnupiravir [WHO-DD]
  • MK-4482
  • Eidd 1931-isopropyl ester
  • EIDD 2801
  • Molnupiravir Impurity 7
  • Molnupiravir Impurity 8
  • RefChem:53379
  • UNII-YA84KI1VEW
  • Molnupiravir Impurity 18
  • pro-EIDD-1931
  • Beta-D-N4-hydroxycytidine
  • Molnupiravir (JAN/USAN)
  • MOLNUPIRAVIR [JAN]
  • Uridine, 4-oxime, 5'-(2-methylpropanoate)
  • EIDD2801
  • EIDD-2801(Molnupiravir)
  • EIDD-1931 ISOPROPYL ESTER
  • EIDD-2801(Molnupiravir)?
  • Molnupiravir (EIDD-2801)
  • CHEBI:180653
  • MFCD32663515
  • C13H19N3O7
  • DTXSID501028058
  • orb1299050
  • orb1689082
  • CHEMBL4650320
  • SCHEMBL21345150
  • SCHEMBL23762545
  • SCHEMBL26089644
  • SCHEMBL29349707
  • EIDD 1931 5'-isopropylester
  • GTPL10737
  • med.21724, Compound 182
  • N4-Hydroxycytidine, 5'-isopropyl ester
  • MK4482
  • BDBM429508
  • DTXCID401767659
  • GLXC-22342
  • N4-hydroxycytidine isopropyl ester
  • Molnupiravir [USAN:INN:WHO-DD]
  • BCP32744
  • EX-A3432
  • MSK178990
  • s8969
  • WHO 11853
  • 1-Boc-3-[(1-pyrrolyl)methyl]piperidine
  • AKOS040758956
  • AT13078
  • MK 4482
  • N(4)-hydroxycytidine 5'-isopropylester
  • AC-35171
  • AE176721
  • AS-84465
  • IM181800
  • TS-09789
  • CID:145996610
  • SARS-CoV-2 antiviral agents: molnupiravir
  • SID:472441492
  • ((2R,3S,4R,5R)-3,4-Dihydroxy-5-(4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl isobutyrate
  • [(2R,3S,4R,5R)-3,4-dihydroxy-5-[4-(hydroxyamino)-2-oxopyrimidin-1-yl]oxolan-2-yl]methyl 2-methylpropanoate
  • N-hydroxy-5'-O-(2-methylpropanoyl)cytidine
  • 2635324-86-4
  • beta-D-N4 Hydroxycytidine-5'-isopropyl ester
  • J3.762.505A
  • D11943
  • G70664
  • beta-D-N(4)-hydroxycytidine-5'-isopropyl ester
  • Uridine, 4-?oxime, 5'-?(2-?methylpropanoate)
  • Uridine, 4-oxime, 5'-(2-methylpropanoate), (4Z)-
  • A936190
  • A937816
  • A969871
  • F987085
  • ((2R,3S,4R,5R)-3,4-dihydroxy-5-((E)-4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl isobutyrate
  • ((2R,3S,4R,5R)-3,4-Dihydroxy-5-((Z)-4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl isobutyrate
  • ((2R,3S,4R,5R)-3,4-Dihydroxy-5-(4-(hydroxyamino)-2-oxopyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl isobutyrate
  • .BETA.-D-N4 HYDROXYCYTIDINE-5'-ISOPROPYL ESTER
  • 2492423-30-8
  • C000656703
  • N-hydroxy-5'-O-(2-methylpropanoyl)-3,4-dihydrocytidine
  • B2706-334395
  • ((2R,3S,4R,5R)-3,4-Dihydroxy-5-((4Z)-4-(hydroxyimino)-2-oxo-3,4- dihydropyrimidin-1(2H)-yl)oxolan-2-yl)methyl 2-methylpropanoate
  • [(2R,3S,4R,5R)-3,4-dihydroxy-5-[(4Z)-4-hydroxyimino-2-oxo-pyrimidin-1-yl]tetrahydrofuran-2-yl]methyl 2-methylpropanoate
  • |A-D-N4 hydroxycytidine-5 inverted exclamation marka-isopropyl ester
  • EIDD 2801; EIDD2801; Uridine, 4-oxime, 5'-(2-methylpropanoate
  • [(2R,3S,4R,5R)-3,4-dihydroxy-5-[(4E)-4-(hydroxyimino)-2-oxo-1,2,3,4-tetrahydropyrimidin-1-yl]oxolan-2-yl]methyl 2-methylpropanoate
  • 2409597-46-0
  • EIDD 2801, Uridine-5'-methylpropanoate-4-oxime, Lagevrio, MK-4482, prodrug-EIDD-1931
  • ((2R,3S,4R,5R)-3,4-dihydroxy-5-((4Z)-4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)oxolan-2-yl)methyl 2-methylpropanoate
  • ((2r,3s,4r,5r)-3,4-dihydroxy-5-(4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidine-1(2h)-yl)tetrahydrofuran-2-yl)methyl isobutyrate
  • [(2R,3S,4R,5R)-3,4-bis(oxidanyl)-5-[4-(oxidanylamino)-2-oxidanylidene-pyrimidin-1-yl]oxolan-2-yl]methyl 2-methylpropanoate
  • [(2R,3S,4R,5R)-3,4-dihydroxy-5-[4-(hydroxyamino)-2-oxo-1,2-dihydropyrimidin-1-yl]oxolan-2-yl]methyl 2-methylpropanoate
  • [(2R,3S,4R,5R)-3,4-dihydroxy-5-[4-(hydroxyimino)-2-oxo-3H-pyrimidin-1-yl]oxolan-2-yl]methyl 2-methylpropanoate
  • {(2R,3S,4R,5R)-3,4-dihydroxy-5-[4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl]tetrahydrofuran-2-yl}methyl 2-methylpropanoate
  • MOV
  • NHC
  • Uridine, 4-oxime, 5'-(2-methylpropanoate), (4Z)- (ACI); EIDD 1931-isopropyl ester; EIDD 2801; Lagevrio; MK-4482; Molnupiravir; ss-D-N4 hydroxycytidine-5'-isopropyl ester; Uridine (4Z)-4-oxime 5'-(2-methylpropanoate)
  • XMO